RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 34-44
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
  • Healthcare: A remedy for long-term investors

    CHICAGO (Reuters) - (The opinions expressed here are those of the author, a columnist for Reuters.) For healthcare, gray is the new black. The fastest-growing segment of the global population is aged 60 and over, according to the United Nations...
  • Illinois among 45 states settling off-label dispute with GlaxoSmithKline

    Illinois among 45 states settling off-label dispute with GlaxoSmithKline
    The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....
  • Is this how we'll cure cancer?

    Is this how we'll cure cancer?
    For 85% of kids with a terrible cancer called acute lymphoblastic leukemia, chemotherapy is a cure-but not for Emily Whitehead. Diagnosed at 5, she suffered an infection from her first round of chemo and nearly lost her legs. Then the cancer came back;...
  • The week in review: scams, refunds, recalls and other consumer news you need to know

     
    Happy Monday! If you're looking for good news, you've come to the wrong place. If you want the dirt on the latest scams, accusations of fraud, recalls and other consumer news, read on for a summary of what the Watchdog......
  • Former head of GlaxoSmithKline in China is accused of bribery

    The former head of GlaxoSmithKline in China was charged with corruption by local authorities after a probe that resulted in accusations that the drug maker ran a wide-ranging bribery scheme that included payoffs to doctors. Chinese police alleged that...
  • Chinese dissident, in TV shaming, apologizes for spilling secrets

    Chinese dissident, in TV shaming, apologizes for spilling secrets
    One of China’s most venerable dissident journalists was paraded¬† on state television Thursday morning, apologizing for spilling state secrets that embarrassed the Chinese Communist Party. The public shaming of Gao Yu, a 70-year-old grandmother who...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • GlaxoSmithKline launches probe into claims of misconduct in Iraq

    British drug-maker GlaxoSmithKline said it is launching an investigation into claims of misconduct in Iraq. The announcement comes months after China began looking into allegations of a bribery ring within the company's business in that country. The...
  • A new era of testing [Commentary]

    A new era of testing [Commentary]
    Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits. The presence of these...